. . . . . . . . . . . . . . "a(SCHEM:\"SB-203580\") -| kin(p(HGNC:MAPK14))" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "We hypothesized that Rituximab may inhibit p38 MAPK activity that regulates IL-10 expression via Sp1. Treatment of 2F7 cells with Rituximab or the p38 inhibitor SB203580 inhibited the constitutive p38 MAPK activity and resulted in the inhibition of Sp1, IL-10, STAT3, and Bcl-2." . . "Selventa" . . . . "2014-07-03T14:32:19.839+02:00"^^ . . .